Effect of Palm Olein Intake on Lipid Profile and Appetite Regulation
NCT ID: NCT02924896
Last Updated: 2025-06-22
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
12 participants
INTERVENTIONAL
2016-09-30
2017-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Palm Olein Intake on Lipid Profile and Fat Deposition
NCT02897674
Supplementation of Oil Palm Phenolics to Healthy Participants
NCT04164446
Study of Acute Effects of Sn-1 and Sn-3 Palmitic Acid-rich or Stearic Acid-rich Fats on Metabolic Markers
NCT01428960
Blended Oil Beneficial for Blood Lipids Management
NCT03964857
Effect of Dietary Fat Type in Combination With High Protein on Plasma Homocysteine Levels
NCT00941837
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Population: 12 healthy males and females aged between 18 and 60 years with body mass index (BMI) between 18.5- 29.9kg/m2 and normal fasting plasma glucose and no evidence of insulin resistance will be recruited. No-pre existing morbidity including cardiac, hepatic or renal disease, history of diabetes, hypertension or hyperlipidaemia.
Treatment: Acclimatization visit: At visit 1, all participants will be given a milkshake like drink containing fat, protein and carbohydrate. A cannula will be inserted for the duration of the study day but no blood will be taken. Studies show than during the first visit stress response can affect the metabolic response to the study drink resulting in inaccurate results.
Study visit 2,3,4: following the acclimatization visit, participants will attend 3 more study visits separated by a week to test the metabolic response to the following fats: palm olein, interesterified palm olein and soybean oil in random order. Participants will be asked to complete a visual analogue scale questionnaire about their appetite at each time point. Fasting and postprandial plasma glucose, insulin, appetite hormones and lipids will be measured.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Arm 1
Palm Olein
Palm olein
60g of palm olein will be given in a milkshake at breakfast
Interesterified palm olein
60g of interesterified palm olein will be given in a milkshake at breakfast
Soybean oil
60g of soybean oil will be given in a milkshake at breakfast
Arm 2
Soybean Oil
Palm olein
60g of palm olein will be given in a milkshake at breakfast
Interesterified palm olein
60g of interesterified palm olein will be given in a milkshake at breakfast
Soybean oil
60g of soybean oil will be given in a milkshake at breakfast
Arm 3
Interesterified Palm Olein
Palm olein
60g of palm olein will be given in a milkshake at breakfast
Interesterified palm olein
60g of interesterified palm olein will be given in a milkshake at breakfast
Soybean oil
60g of soybean oil will be given in a milkshake at breakfast
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Palm olein
60g of palm olein will be given in a milkshake at breakfast
Interesterified palm olein
60g of interesterified palm olein will be given in a milkshake at breakfast
Soybean oil
60g of soybean oil will be given in a milkshake at breakfast
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age between 18-60 years (inclusive)
Exclusion Criteria
* History of type 2 diabetes mellitus, cancer, stomach ulcers, drug abuse or alcoholism, gastrointestinal disorders like Crohn's disease
* Smokers
* On lipid/blood pressure- lowering medication/supplements
* Blood pressure\>140/90 mm Hg
* Fasting total cholesterol \> 6.2 mmol/L
* Fasting triacylglyceride \> 2.0 mmol/L
* Subject must not be allergic to intervention
* Pregnancy and breastfeeding (pregnancy test will be undertaken at the screening visit)
* Subjects taking nutritional supplements or on any weight-loss programs
* Subjects who gained or lost ≥ 3kg weight in the past three months
* Subjects with history of hypo- and hyperthyroidism
* Subjects who are anaemic and those who donated blood within three months of the study
18 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Malaysia Palm Oil Board
OTHER_GOV
Imperial College London
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gary Frost
Role: PRINCIPAL_INVESTIGATOR
Imperial College London
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
NIHR/Wellcome Trust Imperial Clinical Research Facility
London, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol, Statistical Analysis Plan, and Informed Consent Form
Related Links
Access external resources that provide additional context or updates about the study.
Clinical Research Facility official web page
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
16/WA/0117
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.